210 related articles for article (PubMed ID: 27839930)
1. Cost-effectiveness of active surveillance versus hemithyroidectomy for micropapillary thyroid cancer.
Venkatesh S; Pasternak JD; Beninato T; Drake FT; Kluijfhout WP; Liu C; Gosnell JE; Shen WT; Clark OH; Duh QY; Suh I
Surgery; 2017 Jan; 161(1):116-126. PubMed ID: 27839930
[TBL] [Abstract][Full Text] [Related]
2. Thyroid lobectomy as a cost-effective approach in low-risk papillary thyroid cancer versus active surveillance.
Youssef MR; Attia AS; Omar M; Aboueisha M; Freeman MN; Shama M; Kandil E
Surgery; 2022 Jan; 171(1):190-196. PubMed ID: 34384606
[TBL] [Abstract][Full Text] [Related]
3. Lobectomy is a more Cost-Effective Option than Total Thyroidectomy for 1 to 4 cm Papillary Thyroid Carcinoma that do not Possess Clinically Recognizable High-Risk Features.
Lang BH; Wong CKH
Ann Surg Oncol; 2016 Oct; 23(11):3641-3652. PubMed ID: 27221359
[TBL] [Abstract][Full Text] [Related]
4. Cost-effective management of low-risk papillary thyroid carcinoma.
Shrime MG; Goldstein DP; Seaberg RM; Sawka AM; Rotstein L; Freeman JL; Gullane PJ
Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1245-53. PubMed ID: 18086967
[TBL] [Abstract][Full Text] [Related]
5. A cost-effectiveness comparison between early surgery and non-surgical approach for incidental papillary thyroid microcarcinoma.
Lang BH; Wong CK
Eur J Endocrinol; 2015 Sep; 173(3):367-75. PubMed ID: 26104754
[TBL] [Abstract][Full Text] [Related]
6. Routine prophylactic central neck dissection for low-risk papillary thyroid cancer is not cost-effective.
Garcia A; Palmer BJ; Parks NA; Liu TH
Clin Endocrinol (Oxf); 2014 Nov; 81(5):754-61. PubMed ID: 24862564
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of intraoperative pathology examination during diagnostic hemithyroidectomy for unilateral follicular thyroid neoplasms.
Zanocco K; Heller M; Elaraj D; Sturgeon C
J Am Coll Surg; 2013 Oct; 217(4):702-10. PubMed ID: 23810576
[TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness of Long-Term Every Three-Year Versus Annual Postoperative Surveillance for Low-Risk Papillary Thyroid Cancer.
Wu JX; Beni CE; Zanocco KA; Sturgeon C; Yeh MW
Thyroid; 2015 Jul; 25(7):797-803. PubMed ID: 25851702
[TBL] [Abstract][Full Text] [Related]
9. Cost Effectiveness of Routine Laryngoscopy in the Surgical Treatment of Differentiated Thyroid Cancer.
Zanocco K; Kaltman DJ; Wu JX; Fingeret A; Heller KS; Lee JA; Yeh MW; Sosa JA; Sturgeon C
Ann Surg Oncol; 2018 Apr; 25(4):949-956. PubMed ID: 29417402
[TBL] [Abstract][Full Text] [Related]
10. A cost-utility analysis for prophylactic central neck dissection in clinically nodal-negative papillary thyroid carcinoma.
Wong CK; Lang BH
Ann Surg Oncol; 2014 Mar; 21(3):767-77. PubMed ID: 24276639
[TBL] [Abstract][Full Text] [Related]
11. Is There Justification for Total Thyroidectomy in Low-Risk Papillary Thyroid Carcinoma? A Decision-Analysis Model.
Stern S; Hilly O; Horowitz E; Leshno M; Feinmesser R
World J Surg; 2015 Nov; 39(11):2707-17. PubMed ID: 26243560
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of active surveillance versus early surgery for thyroid micropapillary carcinoma based on diagnostic and treatment norms in China.
Lai M; Zhang MM; Qin QQ; An Y; Li YT; Yuan WZ
Front Endocrinol (Lausanne); 2023; 14():1166433. PubMed ID: 37664842
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness of Active Surveillance Compared to Early Surgery of Small Papillary Thyroid Cancer: A Retrospective Study on a Korean Population.
Baek HS; Ha J; Kim K; Bae J; Kim JS; Kim S; Lim DJ; Kim C
J Korean Med Sci; 2023 Aug; 38(34):e264. PubMed ID: 37644680
[TBL] [Abstract][Full Text] [Related]
14. Surgery alone for papillary thyroid microcarcinoma is less costly and more effective than long term active surveillance.
Lin JF; Jonker PKC; Cunich M; Sidhu SB; Delbridge LW; Glover AR; Learoyd DL; Aniss A; Kruijff S; Sywak MS
Surgery; 2020 Jan; 167(1):110-116. PubMed ID: 31543327
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of papillary thyroid cancer surveillance.
Wang LY; Roman BR; Migliacci JC; Palmer FL; Tuttle RM; Shaha AR; Shah JP; Patel SG; Ganly I
Cancer; 2015 Dec; 121(23):4132-40. PubMed ID: 26280253
[TBL] [Abstract][Full Text] [Related]
16. Cost analysis of thyroid lobectomy and intraoperative frozen section versus total thyroidectomy in patients with a cytologic diagnosis of "suspicious for papillary thyroid cancer".
Leiker AJ; Yen TW; Cheung K; Evans DB; Wang TS
Surgery; 2013 Dec; 154(6):1307-13; discussion 1313-4. PubMed ID: 24238049
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Diagnostic Lobectomy Versus Observation for Thyroid Nodules >4 cm.
Lee L; Mitmaker EJ; Chabot JA; Lee JA; Kuo JH
Thyroid; 2016 Feb; 26(2):271-9. PubMed ID: 26715288
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid.
Oda H; Miyauchi A; Ito Y; Sasai H; Masuoka H; Yabuta T; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
Endocr J; 2017 Jan; 64(1):59-64. PubMed ID: 27667647
[TBL] [Abstract][Full Text] [Related]
19. BRAF mutation in papillary thyroid cancer: A cost-utility analysis of preoperative testing.
Lee WS; Palmer BJ; Garcia A; Chong VE; Liu TH
Surgery; 2014 Dec; 156(6):1569-77; discussion 1577-8. PubMed ID: 25444226
[TBL] [Abstract][Full Text] [Related]
20. Routine prophylactic central neck dissection for low-risk papillary thyroid cancer: a cost-effectiveness analysis.
Zanocco K; Elaraj D; Sturgeon C
Surgery; 2013 Dec; 154(6):1148-55; discussion 1154-5. PubMed ID: 24383082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]